Lucintel’s latest market report analyzed that custom antibody provides attractive opportunities in the research and therapeutics applications. The custom antibody market is expected to reach $0.8 billion by 2028 with a CAGR of 10.4%. In this market, antibody development is the largest segment by service, whereas therapeutics is largest by application.
Download Brochure of this report by clicking on https://www.lucintel.com/custom-antibody-market.aspx
Based on service, the custom antibody market is segmented into antibody development, antigen preparation, immunization & hybridoma production, antibody characterization, antibody production & purification, and others. The antibody development segment accounted for the largest share of the market in 2023 and is expected to register the highest CAGR during the forecast period, due to increasing incidence of chronic diseases and rising investment in R&D activities by the market players.
Browse in-depth TOC on “Custom Antibody Market”
100 – Figures/Tables
150 – Pages
The Custom Antibody Market is marked by the presence of several big and small players. Some of the prominent players offering custom antibody include Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Abcam, Cell Signaling Technology, Bio-Rad Laboratories, GenScript, and Rockland Immunochemicals.
Request Sample Report:
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link firstname.lastname@example.org.
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
Dallas, Texas, USA